Skip to main content

Table 1 Demographic, clinical and biomarker characteristics of AD dementia subtypes at baseline

From: Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration

 

CN group

AD group, limbic-predominant (S1)

AD group, typical (S2)

AD group, cortical-predominant (S3)

P value, global comparison (S1, S2 and S3)

Pair-wise comparisons

S1 vs S2

S1 vs S3

S2 vs S3

Demographics

n (%)

179

79 (44.6%)

86 (48.6%)

12 (6.8%)

    

 Age, years

73.8 (6.5)

75.4 (6.9)

73.2 (5.7)

68.0 (7.7)

0.007

0.149

0.015

0.088

 Sex, female (%)

50%

49%

38%

50%

0.332

   

 Education, years

16.6 (2.5)

15.4 (3.1)

15.5 (2.6)

16.3 (2.6)

0.544

   

Cognition

 MMSE

29.1 (1.2)

23.4 (1.9)

23.2 (2.2)

22.0 (2.2)

0.037

0.798

0.165

0.200

 ADNI-MEM

1.04 (0.62)

− 0.85 (0.55)

− 0.90 (0.49)

− 1.31 (0.44)

0.012

1

0.025

0.028

 ADNI-EF

0.92 (0.83)

− 0.65 (0.86)

− 1.11 (0.89)

− 1.73 (0.81)

< 0.001

0.002

< 0.001

0.043

 ADNI-DIFF

0.13 (0.72)

− 0.21 (0.69)

0.21 (0.85)

0.41 (0.74)

< 0.001

0.004

0.029

0.723

 ADNI-VS

0.23 (0.59)

− 0.42 (0.8)

− 0.67 (1.01)

− 1.15 (1.08)

0.085

   

 ADNI-Lan

0.89 (0.71)

− 0.63 (0.95)

− 0.83 (0.88)

− 1.11 (0.78)

0.03

0.406

0.406

0.588

Biomarkers

 APOE ε4 (%)

28%

81%

79%

58%

0.222

   

 AV45-PET SUVR

1.11 (0.18)

1.43 (0.14)

1.47 (0.17)

1.4 (0.17)

0.145

   

 CSF Aβ, pg/ml

1392 (663)

598 (163)

585 (225)

629 (169)

0.686

   

 CSF t-tau, pg/ml

236 (92)

374 (143)

374 (154)

402 (124)

0.978

   

 CSF p-tau, pg/ml

22 (9)

38 (16)

37 (16)

39 (14)

0.881

   

 HV

4.97 (0.38)

4.05 (0.51)

4.1 (0.38)

4.46 (0.46)

0.09

   

 CTV

87.39 (6.28)

75.84 (6.95)

73.99 (6.23)

70.04 (5.88)

0.006

0.136

0.026

0.136

 HV:CTV ratio

57.11 (5.29)

53.67 (7.57)

55.74 (6.61)

64.29 (10.08)

< 0.001

0.136

< 0.001

< 0.001

 WMH

6.1 (10.4)

8.0 (10.0)

5.8 (7.9)

8.1 (12.7)

0.262

   
  1. Values for variables are presented as percentages (for gender and APOE ε4 genotype) or means with standard deviation in parentheses. Missing values are excluded (for numbers of missing values per subtype see Supplementary Table 8). In case of significant main effects, subtypes were compared with the post hoc pairwise t tests with FDR correction. Please note that composite cognitive scores have arbitrary units on scales centred on the original test samples used to develop these scores (including patients and healthy controls) [18,19,20]
  2. S1 limbic-predominant subtype, S2 typical subtype, S3 cortical-predominant subtype, HV hippocampal grey matter volume scaled to total intracranial volume, CTV cortical composite grey matter volume scaled to total intracranial volume